av/gufic-biosciences--big.svg

NSE:GUFICBIO

Gufic Biosciences Limited

  • Stock

INR

Last Close

367.70

02/05 08:51

Market Cap

36.39B

Beta: 0.79

Volume Today

20.99K

Avg: 85.49K

PE Ratio

39.21

PFCF: -

Dividend Yield

0.03%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
314.58M
-
435.32M
38.38%
566.40M
30.11%
784.50M
38.51%
940.84M
19.93%
1.02B
8.14%
1.02B
0.06%
1.05B
3.13%
1.50B
42.41%
1.92B
28.40%
2.09B
8.70%
average payables
406.65M
-
510.78M
25.61%
461.80M
9.59%
571.43M
23.74%
761.77M
33.31%
932.14M
22.37%
1.11B
18.89%
1.27B
14.59%
1.36B
6.79%
1.48B
9.33%
1.63B
9.61%
average receivables
11.65M
-
16.64M
42.80%
411.23M
2,371.50%
899.24M
118.67%
1.17B
29.82%
1.41B
20.42%
1.54B
9.20%
1.77B
15.12%
2.00B
12.96%
2.68B
34.10%
3.22B
20.45%
book value per share
3.50
-
4.39
25.31%
5.81
32.24%
6.88
18.44%
9.68
40.80%
9.89
2.13%
17.89
80.94%
27.76
55.17%
35.87
29.21%
54.04
50.65%
capex per share
-0.32
-
-0.13
61.36%
-0.45
260.42%
-1.06
134.17%
-1.68
58.70%
-4.14
146.16%
-1.47
64.57%
-9.16
524.77%
-19.35
111.21%
11.43
159.10%
capex to depreciation
-0.65
-
-0.26
60.69%
-0.95
270.55%
-1.92
101.73%
-2.82
46.93%
-4.80
70.63%
-0.87
81.86%
-5.18
494.64%
-8.42
62.46%
6.62
178.65%
3.59
45.86%
capex to operating cash flow
-0.23
-
0.22
199.82%
0.80
253.88%
1.70
113.56%
-2.51
247.85%
-0.88
65.06%
-0.16
81.82%
-0.85
432.78%
7.06
929.90%
-15.11
314.18%
0.74
104.87%
capex to revenue
-0.02
-
-0.00
71.04%
-0.01
192.36%
-0.03
95.15%
-0.04
36.16%
-0.11
200.63%
-0.03
74.01%
-0.11
291.07%
-0.27
138.34%
0.14
151.43%
0.09
34.06%
cash per share
0.61
-
0.55
9.92%
0.37
32.92%
-0.15
139.47%
-0.39
166.74%
-0.83
113.35%
1.36
262.96%
2.74
101.63%
4.81
75.67%
1.06
78.04%
days of inventory on hand
162.06
-
175.61
8.36%
186.75
6.34%
239.23
28.10%
189.27
20.88%
220.78
16.64%
133.68
39.45%
98.18
26.55%
201.80
105.54%
183.26
9.19%
151.41
17.38%
days payables outstanding
218.13
-
183.86
15.71%
117.76
35.95%
189.96
61.31%
156.19
17.78%
219.61
40.61%
160.05
27.12%
119.75
25.18%
143.29
19.66%
151.99
6.07%
110.83
27.08%
days sales outstanding
3.50
-
3.39
3.12%
117.68
3,374.78%
120.64
2.51%
139.44
15.58%
150.14
7.67%
119.65
20.31%
90.68
24.21%
108.70
19.87%
149.29
37.34%
140.22
6.08%
debt to assets
0.26
-
0.28
8.96%
0.32
13.72%
0.34
5.61%
0.35
3.68%
0.34
3.41%
0.16
53.54%
0.12
21.32%
0.39
214.26%
0.29
25.23%
0.29
0.92%
debt to equity
1.21
-
1.26
3.97%
1.26
0.47%
1.49
17.65%
1.30
12.80%
1.26
3.24%
0.35
71.74%
0.24
32.57%
0.96
301.60%
0.60
38.04%
0.56
6.04%
dividend yield
0.00
-
0.00
69.24%
0.00
37.58%
0.00
41.66%
0.00
40.60%
0.00
70.13%
0.00
68.89%
0.00
16.71%
0.00
51.33%
0.00
41.36%
InfinityT
Infinity%
earnings yield
0.04
-
0.02
45.81%
0.02
2.72%
0.02
18.28%
0.03
92.59%
0.05
40.88%
0.04
19.13%
0.04
0.36%
0.04
11.07%
0.03
31.95%
InfinityT
Infinity%
enterprise value
1.27B
-
3.59B
183.45%
5.68B
58.05%
9.58B
68.83%
7.21B
24.71%
5.80B
19.60%
11.65B
100.90%
24.67B
111.67%
21.13B
14.34%
32.02B
51.54%
3.07B
90.41%
enterprise value over ebitda
8.56
-
17.76
107.54%
20.34
14.48%
23.41
15.13%
14.45
38.30%
11.45
20.76%
13.59
18.71%
16.74
23.14%
15.40
7.99%
21.63
40.47%
2.22
89.73%
ev to operating cash flow
11.36
-
-83.17
832.26%
-129.07
55.18%
-197.50
53.02%
138.54
170.15%
12.69
90.84%
13.08
3.07%
23.62
80.50%
-79.47
436.51%
-429.41
440.31%
2.99
100.70%
ev to sales
0.84
-
1.78
112.45%
2.28
28.20%
3.18
39.83%
2.06
35.40%
1.62
21.17%
2.39
47.37%
3.17
32.49%
3.06
3.36%
3.97
29.74%
0.37
90.56%
free cash flow per share
1.12
-
-0.68
161.20%
-1.02
49.32%
-1.68
64.83%
-1.01
39.86%
0.58
156.85%
7.72
1,242.12%
1.61
79.10%
-22.09
1,468.99%
-12.19
44.81%
free cash flow yield
0.09
-
-0.02
118.83%
-0.02
6.79%
-0.01
3.44%
-0.01
15.42%
0.01
195.75%
0.07
460.88%
0.01
90.39%
-0.12
1,928.74%
-0.04
64.68%
graham net net
-9.82
-
-11.30
15.11%
-4.95
56.24%
-7.99
61.47%
-7.66
4.12%
-10.68
39.45%
-3.96
62.96%
-2.35
40.67%
-22.76
869.93%
-20.48
10.00%
graham number
6.51
-
9.67
48.58%
13.88
43.55%
17.85
28.54%
24.78
38.86%
22.90
7.58%
42.86
87.12%
78.58
83.36%
81.45
3.65%
103.09
26.56%
income quality
1.71
-
-0.39
122.57%
-0.24
36.74%
-0.30
24.08%
0.24
178.38%
2.00
742.32%
2.01
0.72%
1.09
45.88%
-0.33
130.61%
-0.09
74.05%
1.47
1,801.90%
intangibles to total assets
0.00
-
0.00
44.16%
0.00
56.60%
0.00
653.23%
0.00
186.51%
0.00
19.29%
0.00
27.39%
0.00
3.09%
0.00
32.65%
0.01
552.51%
0.01
5.48%
interest coverage
1.37
-
2.05
49.50%
2.80
37.01%
3.91
39.50%
4.23
8.14%
3.52
16.67%
5.90
67.47%
37.35
532.86%
13.98
62.58%
18.84
34.78%
4.92
73.90%
interest debt per share
4.82
-
6.21
29.00%
8.15
31.14%
11.35
39.28%
13.84
21.99%
13.65
1.35%
7.56
44.62%
7.00
7.40%
35.31
404.38%
33.73
4.49%
inventory turnover
2.25
-
2.08
7.72%
1.95
5.96%
1.53
21.94%
1.93
26.39%
1.65
14.27%
2.73
65.16%
3.72
36.15%
1.81
51.35%
1.99
10.12%
2.41
21.04%
invested capital
1.21
-
1.26
3.97%
1.26
0.47%
1.49
17.65%
1.30
12.80%
1.26
3.24%
0.35
71.74%
0.24
32.57%
0.96
301.60%
7.08B
737,068,287,431.51%
7.65B
7.99%
market cap
986.21M
-
3.21B
225.10%
5.14B
60.19%
8.82B
71.77%
6.27B
28.89%
4.64B
26.05%
11.10B
139.29%
24.14B
117.47%
18.07B
25.13%
28.70B
58.81%
net current asset value
-84.40M
-
14.09M
116.69%
112.49M
698.59%
144.78M
28.71%
283.22M
95.61%
30.94M
89.08%
419.58M
1,256.17%
684.70M
63.19%
-492.43M
171.92%
404.98M
182.24%
562.36M
38.86%
net debt to ebitda
1.90
-
1.90
0.38%
1.93
1.54%
1.86
3.93%
1.88
1.53%
2.29
21.65%
0.65
71.86%
0.36
44.51%
2.23
521.89%
2.24
0.63%
2.22
0.90%
net income per share
0.54
-
0.95
76.18%
1.48
55.83%
2.06
39.51%
2.82
36.94%
2.36
16.37%
4.56
93.52%
9.89
116.68%
8.22
16.85%
8.74
6.33%
operating cash flow per share
1.44
-
-0.56
138.71%
-0.57
1.85%
-0.62
9.65%
0.67
207.33%
4.71
604.47%
9.19
94.91%
10.77
17.27%
-2.74
125.45%
-0.76
72.40%
payables turnover
1.67
-
1.99
18.64%
3.10
56.13%
1.92
38.01%
2.34
21.62%
1.66
28.88%
2.28
37.22%
3.05
33.66%
2.55
16.43%
2.40
5.72%
3.29
37.14%
receivables turnover
104.40
-
107.77
3.23%
3.10
97.12%
3.03
2.45%
2.62
13.48%
2.43
7.13%
3.05
25.48%
4.03
31.94%
3.36
16.58%
2.44
27.19%
2.60
6.47%
research and ddevelopement to revenue
0.00
-
0.01
82.99%
0.02
186.53%
0.01
66.29%
0.01
5.58%
0.00
23.04%
0.01
32.07%
0.01
-
return on tangible assets
0.03
-
0.05
47.32%
0.06
33.37%
0.07
5.78%
0.08
15.75%
0.06
18.23%
0.11
75.76%
0.18
62.93%
0.09
49.67%
0.08
14.45%
0.06
24.43%
revenue per share
19.59
-
26.14
33.42%
32.23
23.28%
38.67
19.99%
45.07
16.55%
36.90
18.12%
50.31
36.32%
80.37
59.76%
71.22
11.38%
81.85
14.92%
roe
0.15
-
0.22
40.59%
0.25
17.84%
0.30
17.79%
0.29
2.74%
0.24
18.11%
0.26
6.95%
0.36
39.64%
0.23
35.65%
0.16
29.42%
0.12
28.36%
roic
0.06
-
0.09
42.88%
0.11
17.43%
0.14
27.39%
0.15
9.33%
0.14
6.29%
0.22
56.29%
0.29
32.48%
0.12
58.34%
0.25
108.23%
0.09
65.76%
sales general and administrative to revenue
0.03
-
0.03
15.70%
0.03
8.60%
0.02
25.31%
0.02
3.88%
0.02
12.50%
0.02
11.59%
0.02
3.00%
0.14
-
shareholders equity per share
3.50
-
4.39
25.31%
5.81
32.24%
6.88
18.44%
9.68
40.80%
9.89
2.13%
17.89
80.94%
27.76
55.17%
35.87
29.21%
54.04
50.65%
stock based compensation to revenue
tangible asset value
270.68M
-
339.38M
25.38%
448.96M
32.29%
534.08M
18.96%
749.82M
40.39%
952.97M
27.09%
1.73B
81.53%
2.69B
55.21%
3.47B
29.28%
5.27B
51.80%
5.95B
12.87%
tangible book value per share
3.50
-
4.39
25.38%
5.80
32.29%
6.86
18.23%
9.63
40.39%
9.83
2.03%
17.84
81.53%
27.70
55.21%
35.87
29.51%
53.47
49.06%
working capital
81.39M
-
159.73M
96.26%
288.87M
80.85%
297.79M
3.09%
461.70M
55.04%
389.13M
15.72%
969.20M
149.07%
1.34B
38.02%
1.76B
31.49%
2.28B
29.86%
2.37B
3.74%

All numbers in INR (except ratios and percentages)